Drug intelligence / Profile preview

corticorelin

Development stage
Approved
Lead developer
Ferring Pharmaceuticals
Modality
Peptides
Administration
Intravenous
01

Overview

Corticorelin is a synthetic 41-amino acid peptide analogue of the endogenous human corticotropin-releasing hormone (CRH), also known as corticotropin-releasing factor (CRF). It is a primary regulator of the hypothalamic-pituitary-adrenal (HPA) axis, acting as a potent agonist at the CRH receptors CRHR1 and CRHR2. Upon administration, it stimulates the anterior pituitary gland to secrete adrenocorticotropic hormone (ACTH), which in turn induces the release of cortisol from the adrenal cortex. Clinically, corticorelin is primarily utilized as a diagnostic agent in the 'corticorelin stimulation test' to evaluate HPA axis function and to differentiate between ACTH-dependent Cushing's syndrome (Cushing's disease) and ectopic ACTH secretion. Beyond its diagnostic role, research conducted by institutions like Universitaire Ziekenhuizen KU Leuven explores its involvement in gastrointestinal (GI) pathophysiology, where stress-induced CRH signaling is linked to altered gut permeability, immune activation, and sensorimotor dysfunction in conditions such as functional dyspepsia and irritable bowel syndrome (IBS).

Brand names
CRH FerringCortiscorActhrel
Other names
corticotropin-release hormonecorticotropin-releasing hormonecorticotropin-releasing factorhuman corticotropin-releasing hormone
02

Targets

CRHR1 (Corticotropin-releasing factor receptor 1)CRHR2 (Corticotropin-releasing hormone receptor 2)

Beyond the preview

Go deeper on corticorelin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on corticorelin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call